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Abstract: Discipline-specific Malaria Eradication Research
Agenda (malERA) Consultative Groups have recognized
several cross-cutting issues that must be addressed to
prevent repetition of some of the mistakes of past malaria
elimination campaigns in future programs. Integrated
research is required to develop a decision-making
framework for the switch from malaria control to
elimination. Similarly, a strong economic case is needed
for the very long-term financial support that is essential
for elimination. Another cross-cutting priority is the
development of improved measures of intensity of
transmission, especially at low and nonrandom levels.
Because sustained malaria elimination is dependent on a
functioning health system, a further key cross-cutting
research question is to determine how inputs for malaria
can strengthen health systems, information systems, and
overall health outcomes. Implementation of elimination
programs must also be accompanied by capacity building
and training to allow the assessment of the impact of new
combinations of interventions, new roles for different
individuals, and the operational research that is needed to
facilitate program expansion. Finally, because community
engagement, knowledge management, communication,
political, and multisectoral support are critical but poorly
understood success factors for malaria elimination,
integrated research into these issues is vital.
Introduction
During their deliberations, scientists in the various Consultative
Groups contributing to the Malaria Eradication Research Agenda
(malERA) concentrated on research questions relevant to their
thematic areas. But, in addition, they also briefly noted many issues
of relevance beyond their own domains. Some of these issues are
likely to be critically important in malaria elimination/eradication
programs. Consequently, they received special attention from the
malERA Consultative Group on Integration Strategies. In this
paper, we focus on the research and development needs of these
important cross-cutting issues, especially in the context of historical
reportsofreasonsforthefailureof past campaigns. Considerationof
these cross-cutting issues, we argue, is essential for regional
elimination and, ultimately, global eradication of malaria, but is
also relevant for scaled-up and improved control of disease.
The Historical Context
The Consultative Group identified many cross-cutting topics of
special significance by examining reports of the failures and
successes of earlier approaches to regional elimination of malaria.
History reveals that political, social and human factors are likely to
be just as important as, if not more important than, biological and
technological factors, and that a multidisciplinary approach to
elimination/eradication is essential. Accordingly, special attention
was given during the malERA consultations to finding synergies
and strategies to prevent the ‘‘silo effects’’ that can occur when
specialist groups work in isolation. It is important to identify
critical partnerships between malaria elimination/eradication
programs and programs in health or education, such as integrated
management of childhood illness. Similarly, it is important to
recognise the need to address social determinants of health for
successful malaria eradication campaigns. Finally, ongoing critical
analysis of the success or failure of current elimination efforts
constitutes a research agenda in its own right, as exemplified in
numerous campaigns against other diseases [1,2].
The Global Malaria Action Plan and Research for
Eradication
The Global Malaria Action Plan (GMAP) [3] is focused
predominantly on control, but nevertheless includes eradication
as an ultimate goal. The malERA process, with its paradigm shift
from control to elimination, has produced significant additions to
GMAP by defining a research agenda that will assist in
interruption of transmission. The malERA process emphasises
the importance of clearly defining the essential research and
development needed to achieve specific goals. That is, it focuses on
the minimal essentials—what we ‘‘need to know’’—rather than
what would be maximally possible to know or even ‘‘nice to
know.’’
Research for Readiness to Attempt Regional or
National Elimination
The GMAP has identified the need to continue and scale up
control of malaria in highly endemic areas for maximal reduction of
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foreseeable future [3]. As the malaria map shrinks and malaria
incidence falls, some countries may consider attacking remaining
foci with an elimination agenda. Many pre-elimination consider-
ations are related directly to the competence and readiness of the
health system, and are discussed in the malERA paper on health
systems and operational research [4]. Decision-makers must also
balancethe consequences of diverting resources from urgent clinical
needs to a problem that by definition is causing little morbidity.
Importantly, decision makers at national and regional levels
may need to be reminded that successful elimination for a few
years will inevitably lead to loss of the naturally acquired immunity
that is a good defence against malaria. Attempts to eliminate
malaria that are not sustained can therefore provide the grounds
for serious epidemics in people of all ages, with rapid loss of the
gains accrued during an elimination program if the program fails
or is stopped prematurely [2,5].
The Malaria Elimination Group has recently highlighted the
immediate needs of governments that are currently facing
important decisions about malaria elimination/eradication [6].
Political commitment is essential; local research agendas for
drug and insecticide resistance must be completed, health
system readiness assessed, and cost-effectiveness analyses under-
taken before deciding to make the long-term investment in
elimination.
From its discussions, the malERA Consultative Group on
Integration concluded that the cross-cutting research and
development agenda in the context of the paradigm shift from
control to eradication must take into account the research
developments of the last few decades. Since the end of the Global
Malaria Eradication Program (GMEP), innovations such as rapid
diagnostic tests, insecticide-treated bednets, and improved
information systems and communication systems have been
developed, and a partially effective vaccine should be available in
the foreseeable future. Thus, an algorithm needs to be defined
and a tool developed for deciding the readiness of the system
for elimination, or even for introduction of one of these
innovations.
The Case for Long-Term Investment for
Eradication
Cross-cutting research is needed to make the case for long-term
investment in eradication for the global public good and to ensure
that financial support is available for the ‘‘last mile’’ before
elimination [7]. This case should align with, and complement,
important and related development themes such as global security,
migration, food security, and climate change. If research findings
suggest that the case is strong, malaria eradication could be
included in global policies for health that follow on from the
Millennium Development Goals beyond 2015 [8]. Importantly, a
development agenda consistent with the Paris Declaration on Aid
Effectiveness and the Accra Agenda for Action [9,10] should be
accompanied by strong harmonization with the GMAP and the
goals of the Roll Back Malaria Partnership [3].
Cross-Cutting Research for a Good Measure of
Transmission in the Later Stages of Elimination
Malaria elimination has a very different endpoint from malaria
control and this change of paradigm demands the development of
specific measures of progress. New infections are a direct measure
of ongoing transmission but require labor-intensive, active
surveillance studies, particularly during the elimination phase in
regions previously experiencing high transmission where immune
individuals are unlikely to experience symptomatic disease. After
some years, as immunity declines, infection is more likely to be
symptomatic and may then be a good surrogate marker for the
detection of continued or resumed transmission during surveil-
lance. Thus, at the end of the process, some years after
elimination has been achieved and the population has lost
clinical immunity, surveillance of clinical cases can become a
guide to transmission. However, there are many years between
the time when transmission can be measured in endemic areas
(albeit with difficulty and high cost) and the time when active
surveillance of occasional cases becomes a useful measure (see
also [11,12]).
Accordingly, elimination programs need rapid, sensitive,
standardised, and reproducible transmission measurement meth-
ods to monitor progress towards the desired goal [13], particularly
when transmission continues at low and nonrandom levels.
Research into and development of new measures that are simpler
than surveillance for incident infections is a high priority in the
cross-cutting research and development agenda. Such measures
could potentially be based on serological or other biomarkers and
used as indicators of readiness for elimination, progress towards
that goal, and as markers of residual foci or reintroduced infection
[12].
In particular, the new and improved measures of transmission
could be used for measurement and certification of the absence of
transmission. Such measures are essential to ensure that the
decision to stop expensive entomological studies or indoor
spraying that inconvenience communities is made at the
appropriate time. Sustained funding is, of course, required to
detect ongoing transmission or reintroduction of disease.
Integration with Strengthened Health Systems
Many past efforts at malaria elimination have failed because the
health system failed during the implementation of stand-alone
programs [2]. This failure, through neglect or at least under-
resourcing during implementation of vertical programs, resulted in
the pessimistic view that malaria can only be eliminated in regions
where economic progress and stable governance are in place that
Summary Points
N Several important cross-cutting issues must be ad-
dressed as the international community or an individual
program moves from malaria control to malaria elimi-
nation/eradication: an integrated decision-making
framework must be constructed for this paradigm shift
N Methods to measure transmission rapidly and cost-
effectively in populations, particularly in low transmis-
sion settings, must be developed; very sensitive indica-
tors of transmission are particularly important late in the
elimination phase
N Elimination programs must be integrated for mutual
benefit with strengthened health systems; better train-
ing and capacity building, better information systems,
and modeling must also be developed
N New or improved tools alone will not be enough;
community engagement andg o o dc o m m u n i c a t i o n
between everyone involved in malaria elimination/
eradication is essential
N A research and development agenda for cross-cutting
issues is presented that should facilitate progress as
programs aiming at malaria elimination/eradication
supersede malaria control programs
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opts for a purely vertical approach, when transmission declines,
patient needs for appropriate diagnosis and treatment in the
general health system become part of the surveillance system and
need to be integrated with existing health system structures for
local responses and central monitoring [2,4]. Moreover, diagnosis
and appropriate treatment can contribute to reduction in
transmission, and good health facilities are essential for manage-
ment of other febrile illnesses. For these reasons, a malaria
elimination program simply cannot succeed in the absence of an
effective health system.
The importance of health systems thinking, the need for setting-
specific and phase-specific integration, and the need for new
approaches to replace the old separation into ‘‘horizontal’’ or
‘‘vertical’’ programs have been discussed by most of the other
malERA Consultative Groups but particularly by the group that
focused on health systems [4]. The consultative groups also
highlighted relevant cross-cutting research and development
agenda topics such as the need to measure synergies between
malaria-specific programs and health systems strengthening, and
the extent to which inputs for malaria elimination can be used to
strengthen population health. Our group concluded that tailoring
an approach to each setting is required, maximising synergy with
the health system for mutual benefit, while maintaining the
integrity of categorical program objectives, and the important
activities of the health system.
Training
All of the consultative groups recognized the need for training
and capacity building in the context of elimination, from discovery
research in the laboratory, through social sciences research in
communities, and on to operational research in the context of
health systems thinking. Master’s level research training that
introduces the principles of a scientific approach, epidemiology,
and evidence-based decision making would benefit anyone
involved in deciding about resource allocation, timing, and
refinement of the elimination approach before, during, and after
any elimination/eradication program. Training for the eradication
research agenda also needs to be accompanied by training of
public health leaders and managers with substantial knowledge of
malaria.
In addition, communities of health systems experts require
research training to help them measure the impacts of an
integrated approach to malaria elimination. ‘‘Elimination science’’
would assess the implementation of changed diagnostic or
surveillance methods, or expanded roles of community health
workers or reporters engaged in active surveillance (‘‘learning in
action’’). The information gleaned through such assessments could
be used for operational research or social science research relevant
to community participation and engagement. It could also be used
by a new cohort of experts in database development, management,
or information technology.
For basic research, which has a longer time frame, academic
expertise needs to be developed and sustained in fields relevant to
technological development such as bioinformatics, genetics, drug
and vaccine discovery, systems thinking, and mathematical
modeling. It also needs to be developed in fields relevant to
health promotion and communication and the enhancement of
these fields by new technology.
Together, these training requirements, particularly those that
focus on the needs of disease-endemic countries, are substantial
and should be the subject of a later specific review.
Information Systems and Modeling for Assessing
Combinations of Intervention Strategies
All the consultative groups acknowledged the importance of strong
information systems that are reliableand responsiveto local needs for
rapid intervention, and that provide inputs to national and regional
databases. The requirements for information systems will change
over time with changes in transmission but an important attribute
of these systems should be harmonization and the avoidance of
unnecessary duplication to meet, for example, special or frequent
requests from funding agencies. Importantly, additional sources of
information have to be integrated into existing information systems
to allow modeling of future interventions, to facilitate the analysis of
system-wide effects for costing and implementation, and to provide a
resource for researchers who are modeling transmission, as discussed
in other malERA articles (also see [4,14]).
In common with surveillance systems, information systems need
to be envisaged as tools for intervention (with a target product
profile and standards to be developed and monitored), rather than
as ends in themselves. The consideration of information systems as
interventions (just as surveillance was defined as an intervention by
the WHO Global Malaria Eradication Program), provides a useful
perspective for the definition of the malERA research and
development agenda and is well discussed elsewhere in this series.
Finally, because the costs and benefits, potential synergies, and
operational assessments of combination strategies are likely to be
different in different environments, modeling emerged as one of
the key cross-cutting themes during the malERA consultation
process. In particular, the use of modeling to assist discussions and
decisions on intervention mixes in time and space emerged as a
high priority cross-cutting theme that is discussed further in the
relevant article in this Supplement [14].
Community Engagement
Successful public health programs are characterized by
community engagement and good communication, but how to
achieve these critical success factors is not well understood.
Community case management and treatments such as piloted in
Tigray [15], can be effective, but support from all sectors of society
is critical, particularly where there is a requirement for
behavioural change. Strategies are required to explain why efforts
against malaria need to be maintained, even when malaria cases
are extremely rare. Conversely, governments also have to choose
the correct time, and explain the rationale for stopping certain
interventions. We need to understand how public perception
affects such decisions and provide guidance for countries on when
certain interventions will no longer be cost-effective, and we have
to communicate this information effectively.
Good communication is essential among malaria researchers. It
is also essential that malaria researchers communicate well with
people involved in health systems, malaria control specialists,
health care workers, funders, stakeholders from public and private
nongovernment sectors, communities, the general population, and
the international community. Research should be undertaken on
the range of factors that influence connectivity, from cultural
aspects to technology, which could be revolutionised by the advent
and availability of new means of communication.
Conclusions
An important part of the malERA process was to identify cross-
cutting issues that could facilitate the achievement of the goal of
elimination, particularly in the light of past failures, and build on
the GMAP that already includes eradication as a long-term goal.
PLoS Medicine | www.plosmedicine.org 3 January 2011 | Volume 8 | Issue 1 | e1000404As recognized by the whole malaria community, integration is a
prerequisite for success.
Tools alone are not enough, but need to be accompanied by
excellent and ongoing coordination, operational research, infor-
mation systems, and monitoring and evaluation supplemented by
active surveillance. Integration with the health system and a
multidisciplinary approach are also essential, providing new tools
and approaches for modeling and for systems thinking about the
concepts and strategy needed to achieve the ultimate goal. In
addition, communication and research into its improvement and
local adaptation are critical; without excellent communication and
community and political engagement, elimination/eradication
programs will not succeed. Moreover the community and the
health system need to be ready with appropriate tools and trained
personnel in place to take on new or specific tasks that need to be
integrated into ongoing activities.
Before attempting elimination, a realistic feasibility assessment is
required to determine readiness for this challenge. Some countries
fall far short of readiness, having tools that are inadequate to
complete the task where force of infection is very high, having
health systems that are weak, or suffering from socio-political and
civil disturbances that make public health practice nearly
impossible. Other countries may simply lack one major prereq-
uisite such as political will, or a drug to overcome resistance to
available antimalarial therapy. Unrealistic promises about malaria
elimination will inevitably lead to disappointment and disillusion
with public health approaches and should be avoided.
We cannot provide estimates of the cost of the research and
development agenda for cross-cutting issues that we present in Box
1, and recognise that further work will be required to delineate
fully all the regulatory and ethical implications of new tools that
have been envisaged or described here. Technology that may
provide solutions may currently be beyond our imagination, but
could be available within a short few years. Importantly, however,
we recognize that very long-term investments will be needed for
the research and development agenda that we have outlined. We
also recognize that we need to build on public/private
partnerships and connections with industry to facilitate new
advances. Nevertheless, we emphasize that, even if elimination
programs are decades away for some countries with very high
transmission, now is the time to start work on the broad and
integrated portfolio of long-term research that is essential if the
goal of malaria eradication is to be achieved.
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Box 1. Summary of the Research and
Development Agenda for Cross-Cutting Issues
N Develop and validate a framework of essential informa-
tion required for making the decision to progress from
scaled-up control to elimination that includes political,
economic, and financial factors. The framework should
recognise variability in epidemiology, the need for
political will to prioritise and/or finance and support
such a long-term project, and the need for locally
effective tools powerful enough to finish the task.
N Develop a long-term investment case for elimination
that should align with important development themes
such as global security, migration, food security, and
climate change.
N Document current and past efforts towards elimination.
N Develop methods and approaches to measure and
monitor transmission in a rapid and cost-effective way
at a population level, especially in very low transmission
settings. These methods and approaches should be used
as metrics for the very sensitive indicators of progress
needed for active surveillance systems required in the
last phases of elimination.
N Define and develop the tools required for a communi-
cation and knowledge management strategy that
encourages community engagement, local health sys-
tem involvement, and the participation of national, and
international stakeholders.
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